greeksoup/ stock research

Chemours (CC) FY2023 results: revenue $6.1 billion, down 11.0% on the year

Chemours Co. (CC) reported revenue of $6.1 billion for fiscal 2023, the year ended 31 December 2023, down 11.0% on the year before. Net income was -$253 million, and diluted earnings per share $-1.70. The figures are the company's own, from the 10-K it filed with the SEC on 27 March 2024.

Revenue
$6.1 billion
-11.0% on the year
FY2016FY2023
Operating margin
-4.0%
11.3% a year earlier
FY2016FY2023
Net income
-$253 million
FY2016FY2023
Diluted EPS
-$1.70
FY2016FY2023

this yearthe year beforeHover a bar for its figure.

The year in brief

The four quarters: Q1 FY2023 · Q2 FY2023 · Q3 FY2023 · Q4 FY2023

Income statement (profit and loss)

$ millionFY2023FY2022FY2021On the yearLast 8 years
Revenue6,0786,8316,345-11.0%
Cost of revenue4,7765,2154,964-8.4%
Gross profit1,3021,6161,381-19.4%
Gross margin21.4%23.7%21.8%
Research and development108118107-8.5%
Selling, general and administrative1,286710592+81.1%
Operating income-245772676
Operating margin-4.0%11.3%10.7%
Interest expense208163185+27.6%
Pre-tax income-318741676
Income tax-66.016368.0
Effective tax raten/a22.0%10.1%
Net income-253578608
Net margin-4.2%8.5%9.6%
Diluted EPS-$1.70$3.65$3.60
$ million except per share.
Read moreFree cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.

Cash flow

$ millionFY2023FY2022FY2021On the yearLast 8 years
Operating cash flow556754814-26.3%
Capital expenditure370307277+20.5%
Free cash flow186447537-58.4%
Free cash flow margin3.1%6.5%8.5%
Cash from investing-229-284220
Cash from financing172-685-554
Depreciation and amortisation309291317+6.2%
Share-based compensation18.027.034.0-33.3%
Buybacks69.0495173-86.1%
Dividends paid149154164-3.2%
Dividend per share$1.00$1.00$1.000.0%
Diluted shares, weighted149m158m169m-5.9%
Shares outstanding at period end149m149m161m+0.1%

Balance sheet

$ millionFY2023FY2022FY2021On the yearLast 8 years
Shareholders' equity7211,1071,081-34.9%
Non-controlling interest2.0n/a1.0
Debt4,0383,6333,749+11.1%
Operating lease liabilities208198179+5.1%
Finance lease liabilities46.049.060.0-6.1%
Other liabilities3,2362,6532,480+22.0%
Total liabilities and equity8,2517,6407,550+8.0%
Fixed assets3,2073,1713,154+1.1%
Goodwill1021021020.0%
Intangible assets3.013.06.0-76.9%
Cash and equivalents1,2031,1021,451+9.2%
Receivables5095096440.0%
Inventory1,3491,4041,099-3.9%
Other assets1,8781,3391,094+40.3%
Total assets8,2517,6407,550+8.0%

10-K for the year ended 31 December 2023, filed 27 March 2024: the filing.